Royal Bank of Canada
TYRA icon

Royal Bank of Canada’s Tyra Biosciences TYRA Stock Holding History

Royal Bank of Canada’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3K Sell
88
-654
-88% -$21.2K ﹤0.01% 6628
2025
Q4 		$19K Sell
742
-414
-36% -$7.6K ﹤0.01% 6090
2025
Q3 		$16K Sell
1,156
-15,057
-93% -$172K ﹤0.01% 6324
2025
Q2 		$156K Buy
16,213
+15,536
+2,295% +$148K ﹤0.01% 5332
2025
Q1 		$6K Sell
677
-97
-13% -$1.25K ﹤0.01% 6320
2024
Q4 		$11K Sell
774
-1,361
-64% -$24.7K ﹤0.01% 6331
2024
Q3 		$50K Buy
2,135
+218
+11% +$4.58K ﹤0.01% 5705
2024
Q2 		$31K Buy
1,917
+1,597
+499% +$27.5K ﹤0.01% 5881
2024
Q1 		$5K Sell
320
-3,924
-92% -$64.4K ﹤0.01% 6467
2023
Q4 		$58K Buy
4,244
+2,110
+99% +$27.3K ﹤0.01% 5923
2023
Q3 		$29K Sell
2,134
-143
-6% -$2.12K ﹤0.01% 6048
2023
Q2 		$39K Buy
2,277
+1,535
+207% +$22.3K ﹤0.01% 5901
2023
Q1 		$12K Sell
742
-2,602
-78% -$30.9K ﹤0.01% 6243
2022
Q4 		$25K Buy
3,344
+3,184
+1,990% +$22.5K ﹤0.01% 6215
2022
Q3 		$1K Buy
160
+86
+116% +$787 ﹤0.01% 7279
2022
Q2 		$1K Sell
74
-651
-90% -$5.18K ﹤0.01% 7212
2022
Q1 		$8K Sell
725
-1,766
-71% -$21K ﹤0.01% 7071
2021
Q4 		$35K Buy
+2,491
New +$49.5K ﹤0.01% 6566

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Royal Bank of Canada's TYRA Position: Q1 2026 in Review

Royal Bank of Canada reduced its Tyra Biosciences (TYRA) stake by 88% in Q1 2026, selling an estimated $21.2K and leaving 88 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #6628.

Royal Bank of Canada first reported a position in TYRA in Q4 2021 and has held it in 18 quarters since. The position peaked at $156K in Q2 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Royal Bank of Canada held 88 shares of Tyra Biosciences worth $3K as of Q1 2026.
  • Royal Bank of Canada sold 654 Tyra Biosciences shares in Q1 2026, an estimated $21.2K.
  • Tyra Biosciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6628 holding.
  • Royal Bank of Canada first reported a position in Tyra Biosciences in Q4 2021 and has held it in 18 quarters since.
  • Royal Bank of Canada's Tyra Biosciences position peaked at $156K in Q2 2025.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.